Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000254409 | SCV000318691 | uncertain significance | Cardiovascular phenotype | 2013-05-27 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Revvity Omics, |
RCV003137859 | SCV003826610 | uncertain significance | not provided | 2022-05-12 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005055805 | SCV005725739 | uncertain significance | not specified | 2024-11-26 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.88147_88149delAAG (p.Lys29383del) results in an in-frame deletion that is predicted to remove 1 amino acid from the encoded protein. The variant allele was found at a frequency of 1.6e-05 in 248740 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.88147_88149delAAG in individuals affected with TTN-related conditions and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 263626). Based on the evidence outlined above, the variant was classified as uncertain significance. |